查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1746637

日本荷尔蒙替代疗法市场报告（按产品、给药途径、疾病类型和地区）2025-2033

Japan Hormone Replacement Therapy Market Report by Product, Route of Administration, Type of Disease, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 120 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2024年，日本荷尔蒙替代疗法市场规模达5.678亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到10.112亿美元，2025-2033年期间的复合年增长率（CAGR）为6.60%。该行业正在经历成长，主要得益于几个关键驱动因素，包括激素紊乱发病率的上升、显着的技术进步、给药技术的持续创新以及政府的支持性项目和报销政策。

荷尔蒙替代疗法 (HRT) 是一种用于治疗个别荷尔蒙失衡的医疗方法。这种疗法透过施用外源性荷尔蒙来补充或取代人体自身产生的荷尔蒙。通常，内分泌科医生或妇科医生等医疗保健提供者会在全面评估患者的病史和症状后开立 HRT 处方。 HRT 的目标是透过持续控制荷尔蒙剂量来缓解与荷尔蒙缺乏或变化相关的症状。治疗过程中会进行严格的监测，以确保荷尔蒙水平保持在理想范围内，从而促进整体健康，并可能减轻荷尔蒙失衡的负面影响。

日本荷尔蒙替代疗法市场趋势：

日本荷尔蒙替代疗法市场正在经历大幅成长，这得益于一系列与全球医疗保健趋势相符的因素。其中一个关键驱动因素是荷尔蒙失衡及相关疾病的盛行率不断上升，而久坐不动的生活方式、压力以及自然老化等因素导致这些疾病在人群中日益普遍。这些因素导致对荷尔蒙替代疗法等治疗干预措施的需求日益增长。此外，患者和医护人员对HRT作为有效治疗方案的认识和接受度不断提高，也使市场受益匪浅。这种日益增长的认知促进了日本市场的扩张。日本人口老化是另一个重要驱动因素，因为随着年龄的增长，荷尔蒙失衡变得越来越普遍。这种人口结构的变化导致老年族群对HRT的需求增加。此外，透皮贴片和植入装置等荷尔蒙给药方法的持续技术进步，使得HRT的给药更加便利、更有针对性。这提高了患者的依从性，改善了治疗效果，进一步推动了市场成长。此外，旨在确保患者能够负担得起HRT治疗的政府扶持措施和优惠的报销政策，也为市场扩张创造了有利条件。这些因素将凸显日本荷尔蒙替代疗法市场在预测期内解决荷尔蒙失衡及相关健康问题方面日益增长的重要性和潜力。

日本荷尔蒙替代疗法市场区隔：

产品洞察：

  • 雌激素替代疗法
  • 人类生长激素替代疗法
  • 甲状腺替代疗法
  • 睾酮替代疗法
  • 其他的

给药途径洞察：

  • 口服
  • 肠外
  • 透皮

疾病类型的见解：

  • 停经
  • 甲状腺功能低下症
  • 男性性腺功能低下
  • 生长激素缺乏症
  • 其他的

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外，报告还提供了所有主要公司的详细资料。

本报告回答的关键问题：

  • 日本荷尔蒙替代疗法市场迄今表现如何？未来几年将如何表现？
  • COVID-19 对日本荷尔蒙替代疗法市场有何影响？
  • 日本荷尔蒙替代疗法市场以产品划分是怎样的？
  • 根据给药途径，日本荷尔蒙替代疗法市场是如何分類的？
  • 日本荷尔蒙替代疗法市场根据疾病类型如何划分？
  • 日本荷尔蒙替代疗法市场的价值链分为哪些阶段？
  • 日本荷尔蒙替代疗法的主要驱动因素和挑战是什么？
  • 日本荷尔蒙替代疗法市场的结构是怎么样的？主要参与者是谁？
  • 日本荷尔蒙替代疗法市场的竞争程度如何？

本报告回答的关键问题：

  • 日本荷尔蒙替代疗法市场迄今表现如何？未来几年将如何表现？
  • COVID-19 对日本荷尔蒙替代疗法市场有何影响？
  • 日本荷尔蒙替代疗法市场以产品划分是怎样的？
  • 根据给药途径，日本荷尔蒙替代疗法市场是如何分類的？
  • 日本荷尔蒙替代疗法市场根据疾病类型如何划分？
  • 日本荷尔蒙替代疗法市场的价值链分为哪些阶段？
  • 日本荷尔蒙替代疗法的主要驱动因素和挑战是什么？
  • 日本荷尔蒙替代疗法市场的结构是怎么样的？主要参与者是谁？
  • 日本荷尔蒙替代疗法市场的竞争程度如何？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：日本荷尔蒙替代疗法市场 - 简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章：日本荷尔蒙替代疗法市场格局

  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）

第六章：日本荷尔蒙替代疗法市场-细分：依产品

  • 雌激素替代疗法
    • 概述
  • 人类生长激素替代疗法
    • 概述
  • 甲状腺替代疗法
    • 概述
  • 睾酮替代疗法
    • 概述
  • 其他的

第七章：日本荷尔蒙替代疗法市场-细分：依给药途径

  • 口服
    • 概述
  • 肠外
    • 概述
  • 透皮
    • 概述

第 8 章：日本荷尔蒙替代疗法市场 - 细分：按疾病类型

  • 停经
    • 概述
  • 甲状腺功能低下症
    • 概述
  • 男性性腺功能低下
    • 概述
  • 生长激素缺乏症
    • 概述
  • 其他的

第九章：日本荷尔蒙替代疗法市场-竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳获胜策略
  • 竞争仪錶板
  • 公司评估象限

第十章：关键参与者简介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 11 章：日本荷尔蒙替代疗法市场-产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 驱动程式
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 12 章：附录

简介目录
Product Code: SR112025A19204

Japan hormone replacement therapy market size reached USD 567.8 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,011.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.60% during 2025-2033. The industry is experiencing growth due to several key drivers, including the increasing incidence of hormonal disorders, notable technological advancements, continuous innovations in delivery techniques, and supportive government programs and reimbursement policies.

Hormone replacement therapy (HRT) is a medical approach employed to address hormonal imbalances in individuals. This treatment involves the administration of external hormones to supplement or substitute the natural hormones produced by the body. Typically, healthcare providers, such as endocrinologists or gynecologists, prescribe HRT after a comprehensive assessment of the patient's medical history and symptoms. HRT's objective is to alleviate symptoms related to hormonal deficiencies or variations by consistently delivering controlled hormone doses. The treatment undergoes careful monitoring to ensure that hormone levels remain within the desired range, promoting overall well-being and potentially mitigating the negative effects of hormonal imbalances.

Japan Hormone Replacement Therapy Market Trends:

The Japan hormone replacement therapy market is experiencing substantial growth, driven by a combination of factors that align with global healthcare trends. A key driver is the increasing prevalence of hormonal imbalances and related disorders, which are becoming more prevalent in the population due to factors like sedentary lifestyles, stress, and the natural process of aging. These factors have created a growing need for therapeutic interventions such as hormone replacement therapy. Furthermore, the market benefits from the rising awareness and acceptance of HRT as an effective treatment option among both patients and healthcare professionals. This increasing recognition has contributed to the expansion of the market in Japan. The aging demographic in Japan is another significant driver, as hormonal imbalances become more common with age. This demographic shift has led to a higher demand for HRT among the elderly population. Moreover, ongoing technological advancements in hormone delivery methods, such as transdermal patches and implantable devices, are making HRT more convenient and targeted in its administration. This enhances patient compliance and improves treatment outcomes, further fueling market growth. Additionally, supportive government initiatives and favorable reimbursement policies aimed at ensuring affordable access to HRT for patients are creating favorable conditions for market expansion. These collective factors will underscore the growing importance and potential of the Japan hormone replacement therapy market in addressing hormonal imbalances and related health concerns over the forecasted period.

Japan Hormone Replacement Therapy Market Segmentation:

Product Insights:

  • Estrogen Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Thyroid Replacement Therapy
  • Testosterone Replacement Therapy
  • Others

Route of Administration Insights:

  • Oral
  • Parenteral
  • Transdermal

Type of Disease Insights:

  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan hormone replacement therapy market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan hormone replacement therapy market?
  • What is the breakup of the Japan hormone replacement therapy market on the basis of product?
  • What is the breakup of the Japan hormone replacement therapy market on the basis of route of administration?
  • What is the breakup of the Japan hormone replacement therapy market on the basis of type of disease?
  • What are the various stages in the value chain of the Japan hormone replacement therapy market?
  • What are the key driving factors and challenges in the Japan hormone replacement therapy?
  • What is the structure of the Japan hormone replacement therapy market and who are the key players?
  • What is the degree of competition in the Japan hormone replacement therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Hormone Replacement Therapy Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Hormone Replacement Therapy Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Hormone Replacement Therapy Market - Breakup by Product

  • 6.1 Estrogen Replacement Therapy
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Human Growth Hormone Replacement Therapy
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Thyroid Replacement Therapy
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Testosterone Replacement Therapy
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 Others
    • 6.5.1 Historical and Current Market Trends (2019-2024)
    • 6.5.2 Market Forecast (2025-2033)

7 Japan Hormone Replacement Therapy Market - Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Parenteral
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Transdermal
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)

8 Japan Hormone Replacement Therapy Market - Breakup by Type of Disease

  • 8.1 Menopause
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Hypothyroidism
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Male Hypogonadism
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2019-2024)
    • 8.3.3 Market Forecast (2025-2033)
  • 8.4 Growth Hormone Deficiency
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2019-2024)
    • 8.4.3 Market Forecast (2025-2033)
  • 8.5 Others
    • 8.5.1 Historical and Current Market Trends (2019-2024)
    • 8.5.2 Market Forecast (2025-2033)

9 Japan Hormone Replacement Therapy Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Hormone Replacement Therapy Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix